Replies to post #285359 on Avid Bioservices Inc (CDMO)

[biopharm]

Alan Epstein also speaks...

Cheynew, that was Jan 2018 for Alan Epstein but he speaks much sooner ....also notice latest Peregrine collaborator Epiontis is in house and you get that feeling that Peregrine still has an Ace up the sleeve? ....maybe they had a few Aces and they still have one to play

https://www.gtcbio.com/conferences/novel-cancer-therapeutics-summit/?section=speakers

http://www.epiontis.com/events/

[biopharm]

Alan Epstein also likes MDSCs and was he involved with any questioning from FBI at MD Anderson ?

Such a pivotal coincidence as Pivotal Bioventure that recruited Laura Benjamin to hide the IP of PS Targeting

____

Alan L. Epstein, M.D., Ph.D.
Professor of Pathology, USC Keck School of Medicine
Greater Los Angeles Area
Biotechnology300

Experience

Department of Pathology and Laboratory Medicine
Professor of Pathology, Department of Pathology and Laboratory Medicine

Keck School of Medicine of USC
1984 - Present 35 years

Greater Los Angeles Area

Active in the field of cancer immunotherapy including the development of antibody fusion proteins, immunoconjugates, and targeting antibodies to the tumor microenvironment. In addition, developed a new biomarker assay for cancer which quantitates myeloid derived suppressor cells as a measure of tumor burdern and recurrence using flow cytometry and antibodies developed in the laboratory.

Department of Medicine
Adjunct Professor, Department of Medicine
MD Anderson Cancer Center
1994 - Present 25 years
Houston, Texas Area

Founder
Pivotal BioSciences, Inc.
2001 - 2011 10 years
Greater Los Angeles Area